How to Participate in the PHOCUS Trial
To join the trial, patients must:
- Have advanced stage liver cancer (also called hepatocellular carcinoma or HCC). Liver cancer is a cancer that originates from the liver (not a cancer that started in a different organ of the body and spread to the liver).
- Have never received systemic medicine (affecting the entire body) for advanced liver cancer and are an appropriate candidate for sorafenib (Nexavar®) therapy.
- Be able to take care of daily activities by themselves.
There are some other guidelines as well. Take this information to your doctor to see if this trial is an option for you.